Vor Biopharma's total assets for Q2 2025 were $205.37M, an increase of 87.88% from the previous quarter. VOR total liabilities were $1.71B for the fiscal quarter, a 3856.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.